We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-14.47%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.96B
AUM Growth
-$2.66B
Cap. Flow
-$2.46B
Cap. Flow %
-41.33%
Top 10 Hldgs %
19.41%
Holding
1,586
New
385
Increased
156
Reduced
122
Closed
320

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$45.3M
2
DELL icon
Dell
DELL
+$42.5M
3
JD icon
JD.com
JD
+$38.9M
4
TSM icon
TSMC
TSM
+$32.4M
5
ACC
American Campus Communities, Inc.
ACC
+$31.6M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Financials 9.38%
3 Healthcare 5.16%
4 Consumer Discretionary 4.89%
5 Communication Services 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQB icon
1126
AquaBounty Technologies
AQB
$4.63M
$40K ﹤0.01%
+1,168
New +$35.7K
DAKT icon
1127
Daktronics
DAKT
$956M
$40K ﹤0.01%
+13,246
New +$44.3K
DS
1128
DELISTED
Drive Shack Inc.
DS
$40K ﹤0.01%
+29,467
New +$42K
EMKR
1129
DELISTED
Emcore Corp
EMKR
$40K ﹤0.01%
+1,318
New +$44.4K
KLTR icon
1130
Kaltura
KLTR
$220M
$39K ﹤0.01%
+19,613
New +$33.6K
NNBR icon
1131
NN Inc
NNBR
$273M
$39K ﹤0.01%
+15,246
New +$42.3K
PPTA
1132
Perpetua Resources
PPTA
$2.28B
$38K ﹤0.01%
+11,589
New +$41.6K
ADVM
1133
DELISTED
Adverum Biotechnologies
ADVM
$37K ﹤0.01%
+3,099
New +$32.5K
LITS
1134
Lite Strategy Inc
LITS
$33.2M
$37K ﹤0.01%
+3,041
New +$33.1K
GRTS
1135
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$37K ﹤0.01%
+15,240
New +$40K
CUE icon
1136
Cue Biopharma
CUE
$137M
$36K ﹤0.01%
+488
New +$57.1K
IMUX icon
1137
Immunic
IMUX
$188M
$35K ﹤0.01%
+1,000
New +$64.1K
ZY
1138
DELISTED
Zymergen Inc. Common Stock
ZY
$35K ﹤0.01%
+28,599
New +$47.9K
PRTK
1139
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$34K ﹤0.01%
+17,469
New +$38.1K
PBYI icon
1140
Puma Biotechnology
PBYI
$407M
$33K ﹤0.01%
+11,514
New +$28.6K
STXS icon
1141
Stereotaxis
STXS
$130M
$33K ﹤0.01%
+17,703
New +$42.3K
ASXC
1142
DELISTED
Asensus Surgical, Inc.
ASXC
$33K ﹤0.01%
+83,462
New +$37.2K
FUV
1143
DELISTED
Arcimoto, Inc. Common Stock
FUV
$33K ﹤0.01%
+511
New +$40.5K
CTSO icon
1144
Cytosorbents Corp
CTSO
$22.6M
$32K ﹤0.01%
+14,709
New +$33.8K
PAVM icon
1145
PAVmed
PAVM
$37.2M
$32K ﹤0.01%
+77
New +$37.2K
SEEL
1146
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$32K ﹤0.01%
+12
New +$31.3K
TRVN
1147
DELISTED
Trevena, Inc.
TRVN
$32K ﹤0.01%
+124
New +$27.3K
TCRR
1148
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$32K ﹤0.01%
+10,880
New +$26.8K
KOPN icon
1149
Kopin
KOPN
$687M
$31K ﹤0.01%
+27,682
New +$41.5K
PASG icon
1150
Passage Bio
PASG
$14.8M
$31K ﹤0.01%
+661
New +$30.9K

Similar funds

LMR Partners's Q2 2022 Portfolio in Review

As of Q2 2022, LMR Partners held 1,586 positions worth $5.96B, down 31% from $8.61B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

LMR Partners withdrew a net $2.46B in Q2 2022, closing 320 positions and reducing 122 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Microsoft worth $42.8M.

  • LMR Partners's largest Q2 2022 buy was Microsoft: 166,753 shares worth $42.8M.
  • LMR Partners added most to TSMC in Q2 2022, an estimated $32.4M increase.
  • LMR Partners's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $553M.
  • LMR Partners fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $117M.
  • LMR Partners's ten largest holdings make up 19% of its $5.96B portfolio in Q2 2022.
  • LMR Partners opened 385 new positions and closed 320 in Q2 2022.
  • LMR Partners's portfolio value fell 31% quarter-over-quarter to $5.96B.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.